|
Titan Medical Inc. Announces the Appointment of New Director - 02 06 2009 TORONTO, ONTARIO--(Marketwire – June 2, 2009) – Titan Medical Inc. ("the Company") (TSX VENTURE:TMD), today announced that the shareholders elected Mr. John E. Barker as a Director of the Company at their annual meeting on May 28, 2009.
As former Senior Vice President of Finance and Chief Financial Officer of Zenon Environmental Inc., having had sales exceeding $230 million and 1,480 employees, Mr. Barker was responsible for managing the finance and information technology of over 35 subsidiary companies in 25 different countries. Most notably, he led teams that raised over $140 million of capital between 2002 and 2004, and assisted with the sale of Zenon Environmental Inc. to General Electric Company for a 50% premium over the share price. On November 6, 2008, the Company announced that it had entered into a consulting agreement with Mr. Barker as a strategic advisor to the Company.
"I am extremely pleased to have John Barker as our new Director. He brings invaluable management and board experience from Canadian listed corporations. His presence on our Board will be a welcome asset as we advance our efforts in the development and commercialization of Amadeus®, the next generation robotic surgical system" said Craig Leon, Chief Executive Officer.
The shareholders also reelected existing directors Mr. Craig Leon, Dr. Reiza Rayman, Mr. Martin Bernholz and Mr. William Jackson to a second term.
About Titan Medical Inc.: Titan Medical Inc. is a Canadian public company (TSX VENTURE:TMD) focused on the development and commercialization of robotic surgical technologies. The Company is currently developing Amadeus®, a next generation 4-armed robotic surgical system, with the objective of enabling surgeons to remotely manipulate surgical instruments. Robotic surgery has developed over the past 10 years into a proven and growing method of treatment. The global robotic surgical market size is currently estimated to be $3.4 billion with potential for placement of 6,000 robotic surgical systems. The Company is researching and developing innovative technologies to empower surgeons to use robots in the operating room of the future. For more information, visit the Company’s website at www.titanmedicalinc.com.
The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.
FOR FURTHER INFORMATION PLEASE CONTACT:
Craig Leon
Titan Medical Inc.
Chief Executive Officer
Ph. (416) 548-7522 (ext. 151)
Fax: (416) 368-1608
Email: cleon@titanmedicalinc.com
|
